Sensei Biotherapeutics Stock (NASDAQ: SNSE) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 38.000 / 70.679K |
Day Range | - - - |
52 Wk Range | 0.510 - 1.720 |
Market Cap | $25.572M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 1.09% |
Days to Cover | 2.61 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Sensei Biotherapeutics (NASDAQ: SNSE) through any online brokerage.
Other companies in Sensei Biotherapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Serina Therapeutics (AMEX:SER), T2 Biosystems (NASDAQ:TTOO), Lumos Pharma (NASDAQ:LUMO) and Evaxion Biotech (NASDAQ:EVAX).
The latest price target for Sensei Biotherapeutics (NASDAQ: SNSE) was reported by HC Wainwright & Co. on Monday, December 4, 2023. The analyst firm set a price target for 4.00 expecting SNSE to rise to within 12 months (a possible 292.16% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Sensei Biotherapeutics (NASDAQ: SNSE) is $1.02 last updated April 25, 2024 at 9:28 AM EDT.
There are no upcoming dividends for Sensei Biotherapeutics.
Sensei Biotherapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Sensei Biotherapeutics.
Sensei Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.